Research Leads to New Treatment for Lymphoma in Dogs and Cats

North Port, FL, January 13, 2016 --(PR.com)-- Research presented at the AACR Dead Sea International Conference on Advances in Cancer Research has found that fucoidan, a compound found in common brown seaweed may hold the answer to cancers of the immune system, specifically lymphoma.

At the conference, researchers from the Hashemite University in Jordan presented their findings that the fucoidan found in brown seaweed effectively kills cancer tumors.

The study used an extract of brown seaweed on lymphoma cell lines that had been cultivated in the laboratory. When the lymphoma cells were treated with the extract, lymphoma cell growth was suppressed, while healthy cells were left intact.

Researchers further noted there was a significant increase in apoptosis, which is cellular death, in the lymphoma cells.

Mohammad Irhimeh, Ph.D, assistant professor of hematoncology and stem cells at the Hashemite University in Jordan said, "Some forms of B-cell lymphoma are especially resistant to standard treatment and thus new therapies are needed, in this study, we looked at a new treatment strategy using novel active compounds derived from a natural source -- seaweed."

Joanne Genco, owner of Rejenavite, LLC, added, "The effects of fucoidan on lymphoma cells is of utmost importance to pet owners, as lymphoma is the most prevalent cancer in dogs and cats. We have carefully followed the research, and believe it is just a matter of time before all pet owners are advised to include fucoidan-rich supplementation daily to suppress this serious condition.

"We invite all pet owners to visit our http://fucopia.com for more information and updates on research."